Stand Up To Cancer has had a major role in galvanizing immunotherapy approaches. The big opportunity is to take immunotherapy from the early stage ideas and get it out to where the public can benefit.
- Carl H. June, MD
- Leader SU2C-Lustgarten Foundation CAR T Cell Translational Research Team
Immunotherapy, an exciting approach to cancer treatment, works by empowering your body’s own immune system to correctly identify and eradicate cancer cells. This approach has been used to effectively fight many types of cancer, with new research leading to greater hope each day.
Immunotherapy enables the immune system to recognize and target cancer cells, making it a universal form of treatment. Currently, immunotherapy can be used to treat forms of these cancers:
Many researchers believe it has the power to be the cure for all cancer types, including:
Currently, only six active immunotherapies have been approved for cancer, meaning hundreds of other new and promising cancer immunotherapy treatments are only available to patients in clinical trials. Participation in these types of clinical trials may be the most promising treatment option for patients facing cancer today and is critical to the development and approval of these treatments in the future.
Don’t hesitate to ask questions. Talk to your doctor, research nurse and the rest of your medical care team about clinical trials they might recommend or ones you’ve found online. They are often your best resource for helping you navigate available treatment options.
In general, the questions you will want to ask are similar to those you would ask your doctor about any type of treatment. Knowing both your treatment and clinical trial options will help you make the most informed decision.
If your doctor recommends a trial, you will want to learn more about what treatment the trial involves, possible side effects from the treatment, financial responsibility, if travel is involved and how long the treatment will last.
The latest cancer treatment advances, like immunotherapy, have been made possible because of patients who have participated in clinical trials.
SU2C is pleased to connect interested parties with EmergingMed, a free and confidential trial matching service that will help guide you through a search and referral process to find a clinical trial that may be right for you.
A Clinical Trial Navigator will be in touch with you within one business day to answer your questions about clinical trials and help guide you through the search process.
SU2C is proud to be among the organizations at the forefront of immunotherapy research and clinical trials, through SU2C Dream Teams and SU2C Research Grants.
To learn more about SU2C Catalyst® teams that are focusing on immunotherapy visit SU2C.org/Catalyst.
Below are the SU2C research teams focusing on immunotherapy: